Envista Q2 sales $645.8M (+1.3%), core sales +4.0%; adj EPS $0.48; guidance revised to mid-single digits growth

Envista Holdings Corp

2022-Q2 EPS reported $0.68 revenue$1,277,200,000

Sales $645.8M (+1.3% YoY), core sales growth 4.0%; net income $44.5M ($0.25 diluted EPS).
Adjusted net income $86.0M, adjusted EPS $0.48 (vs $0.46 in Q2 2021); adjusted EBITDA $126.9M, margin 19.7%.
FY 2022 guidance: core sales growth revised to mid-single digits; maintains adjusted EBITDA margin target of 20%.
Closed acquisitions of Carestream Dental's IOS business (Q2) and Osteogenics Regenerative Solutions (July).
Cites headwinds: supply chain disruptions, inflation, geopolitical uncertainties, China COVID lockdown.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.